Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration

American Journal of Ophthalmology

Volumn 134, Issue 4, 2002, Pages 577-585

  Rodanant, Nuttawut ^a   Friberg, Thomas R ^b   Cheng, Lingyun ^a   Aurora, Ajay ^a   Bartsch, Dirk Uwe ^a   Toyoguchi, Mitsuko ^a   Corbin, Patricia S ^b   El Bradey, Mohamed H ^a   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIODE LASER; DRUSEN; EYE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYPERPIGMENTATION; LASER COAGULATION; LOW LEVEL LASER THERAPY; MALE; PHOTOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RETINA; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; FEMALE; FLUORESCEIN ANGIOGRAPHY; FORECASTING; FUNDUS OCULI; HUMANS; INFRARED RAYS; LASER COAGULATION; MACULAR DEGENERATION; MALE; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; RETINAL DRUSEN; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0036808606     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01691-4     Document Type: Article

References (38)

1. Gass J.D. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 90:1973;206-217.
2. Bressler N.M., Munoz B., Maguire M.G., et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities Waterman study . Arch Ophthalmol. 113:1995;301-308.
3. Klein R., Klein B.E.K., Jensen S.C., Meuer S.M. The five-year incidence and progression of age-related maculopathy The Beaver Dam Eye Study . Ophthalmology. 104:1997;7-21.
4. Macular Photocoagulation Study Group . Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol. 115:1997;741-747.
5. Moisseive J., Alhalel A., Masuri R., Treister G. The impact of the macular photocoagulation study. Results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol. 113:1995;185-189.
6. Freund K.B., Yannuzzi L.A., Sorenson J.A. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol. 115:1993;786-791.
7. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy(TAP) Study Group Verteporfin (Visudyne) therapy of subfoveal choroidal neovascularization in age-related macular degeneration one year results of two randomized clinical trials - TAP . Report#1 Arch Ophthalmol. 117:1999;1329-1345.
8. Lanchony D.M., Maguire M.G., Fine S.L. A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients . Arch Ophthalmol. 116:1998;1045-1052.
9. Gass J.D. Photocoagulation of macular lesions. Trans Am Acad Ophthalmol Otolaryngol. 75:1971;580-608.
10. Cleasby G., Nakanishi A.S., Norris J.L. Prophylactic photocoagulation of the fellow eye in exudative senile maculopathy. Mod Probl Ophthalmol. 20:1979;141-147.
11. Wetzig P.C. Treatment of drusen-related aging macular degeneration by photocoagulation. Trans Am Ophthalmol Soc. LXXXVI:1988;276-290.
12. Wetzig P.C. Photocoagulation of drusen-related macular degeneration a long-term outcome . Trans Am Ophthalmol Soc. XCII:1994;299-306.
13. Sigelman J. Foveal drusen resorption one year after perifoveal laser photocoagulation. Ophthalmology. 98:1991;1379-1383.
14. Sarks S.H., Arnold J.J., Sarks J.P., et al. Prophylactic perifoveal laser treatment of soft drusen. Aust N Z J Ophthalmol. 24:1996;15-26.
15. Hyver S.W., Schatz H., McDonald H.R., Johnson R.N. A case of visual acuity loss following laser photocoagulation for macular drusen. Arch Ophthalmol. 115:1997;554.
16. Figueroa M.S., Regueras A., Bertrand J. Laser photocoagulation to treat macular soft drusen in age- related macular degeneration. Retina. 14:1994;391-394.
17. Figueroa M.S., Regueras A., Bertrand J., Aparicio M.J., Manrique M.G. Laser photocoagulation to treat macular soft drusen Update results . Retina. 17:1997;378-384.
18. Bressler S.B., Vitale S., Hawkins B.S., et al. Laser to drusen trial an assessment of short term safety within a randomized, prospective, controlled clinical trial . Invest Ophthalmol Vis Sci. 36:1995;1028.
19. Guymer R.H., Gross-Jendroska M., Owens S.L., et al. Laser treatment in subjects with high-risk clinical features of age-related macular degeneration. Arch Ophthalmol. 115:1997;595-603.
20. Brancato R., Trabucchi G., Introini U., Avanza P. Hyperfluorescent plaque lesions in the late phases of indocyanine green angiography a possible contraindication to the laser treatment of drusen . Am J Ophthalmol. 124:1997;554-555.
21. Little H.L., Showman J.M., Brown B.W. A pilot randomized controlled study of the effect of laser photocoagulation of confluent soft macular drusen. Ophthalmology. 104:1997;623-631.
22. Frennesson I.C., Nilsson S.E.G. Effect of argon (green) laser treatment of soft drusen in early age-related maculopathy a 6-month prospective study . Br J Ophthalmol. 79:1995;905-919.
23. Frennesson I.C., Nilsson S.E.G. Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications. Br J Ophthalmol. 82:1998;1169-1174.
24. Choroidal Neovascularization Trial Research Group . Laser treatment in eyes with large drusen short-term effects seen in a pilot randomized clinical trial . Ophthalmology. 105:1998;11-23.
25. Choroidal Neovascularization Trial Research Group . Choroidal neovascularization in the CNVPT. Ophthalmology. 105:1998;1364-1372.
26. Ho A.C., Maguire M.G., Yoken J., Lee M.L., et al. Laser induced drusen reduction improves visual function at 1 year. Ophthalmology. 106:1999;1367-1374.
27. Kaiser R.S., Burger J.W., Maguire M.G., Ho A.C., et al. Laser burn intensity and risk for choroidal neovascularization in the CNVPT Fellow Eye Study. Arch Ophthalmol. 119:2001;826-832.
28. Olk R.J., Friberg T.R., Stickney K.L., et al. Therapeutic benefits of infrared (810 nm) diode laser photocoagulation in prophylactic treatment of non-exudative age-related macular degeneration. Two-year results of a randomized pilot study. Ophthalmology. 106:1999;2082-2090.
29. Olk R.J., Friberg T.R., Olk H.R., et al. Therapeutic benefits of diode laser grid photocoagulation in prophylactic treatment of age related macular degeneration long-term (4-5 years):results of a randomized pilot study. Invest Ophthalmol Vis Sci (Suppl). 319:2000.
30. Burger J.W. Wavelength considerations for laser prophylaxis in AMD. Ophthalmology. 107:2000;1019-1020.
31. Sato Y., Berkowitz B.A., Wilson C.A., de Jaun E. Jr. Blood-retinal barrier breakdown caused by diode versus argon laser endophotocoagulation. Arch Ophthalmol. 110:1992;277-281.
32. Burger J.W. Thermal modeling of micropulsed diode laser retinal photocoagulation. Laser Surg Med. 20:1997;409-415.
33. Pollack J.S., Kim J.E., Pulido J.S., Burke J.M. Tissue effects of subclinical diode laser treatment of the retina. Arch Ophthalmol. 116:1998;1633-1636.
34. Burger J.W. Macular laser-tissue interactions. Implications for prophylaxis and treatment. Burger J.W., Fine S.L., Maguire M.G., Age-related macular degeneration. 1999;Mosby, St. Louis, MO.
35. Roider J., Brinkmann R., Wirbelauer C., et al. Variability of RPE reaction in two cases after selective RPE laser effects in prophylactic treatment of drusen. Graefes Arch Clin Exp Ophthalmol. 237:1999;45-50.
36. Banker A.S., Freeman W.R., Kim J.W., et al. Vision-threatening complications of surgery for full thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmology. 104:1997;1442-1452.
37. Javornik N., et al. Changes in drusen and RPE abnormalities in age-related macular degeneration. Invest Ophthalmol Vis Sci (Suppl). 33:1992;1230.
38. Duvall J., Tso M.O. Cellular mechanisms of drusen after laser coagulation an experimental study . Arch Ophthalmol. 103:1985;694-703.